These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Ferner RE Lancet Neurol; 2007 Apr; 6(4):340-51. PubMed ID: 17362838 [TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms. Ruggieri M; Praticò AD; Evans DG Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012 [TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Evans DG Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378 [TBL] [Abstract][Full Text] [Related]
16. Mouse models of neurofibromatosis 1 and 2. Gutmann DH; Giovannini M Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543 [TBL] [Abstract][Full Text] [Related]
17. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315 [TBL] [Abstract][Full Text] [Related]
18. Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2. Kotch C; Brosius SN; De Raedt T; Fisher MJ Pediatr Neurosurg; 2023; 58(5):267-280. PubMed ID: 36746138 [TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 2. Slattery WH Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141 [TBL] [Abstract][Full Text] [Related]
20. [Phacomatosis and genetically determined tumors: the transition from childhood to adulthood]. de Ribaupierre S; Vernet O; Vinchon M; Rilliet B Neurochirurgie; 2008 Oct; 54(5):642-53. PubMed ID: 18752812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]